Fellahi J L, Bénard P, Daccache G, Mourgeon E, Gérard J L
Service d'anesthésie-réanimation, centre hospitalier privé Saint-Martin, 18, rue des Roquemonts, 14050 Caen, France.
Ann Fr Anesth Reanim. 2003 Jul;22(7):631-4. doi: 10.1016/s0750-7658(03)00218-1.
We report two patients in vasodilatory septic shock refractory to catecholamines in which a continuous infusion of terlipressin was associated with a dramatic increase in systemic arterial blood pressure and short-term survival. Low doses of terlipressin were sufficient in both cases (0.01-0.0 mg h(-1)) to restore blood pressure by increase of systemic vascular resistances. The haemodynamic response was immediate, long-acting, dose-dependent and reversible in a few hours when the drug administration was stopped. A further increase in terlipressin dose regimen markedly decreased cardiac performance. Terlipressin simultaneously induced vasoconstriction within the cutaneous vascular territory, leading to local skin necrosis. The splanchnic vascular territory seemed to be constricted in the same way. Further studies are needed to better understand and precise the role of terlipressin in the treatment of vasodilatory septic shock refractory to catecholamines.
我们报告了两名对儿茶酚胺难治的血管扩张性感染性休克患者,持续输注特利加压素与体循环动脉血压显著升高及短期生存相关。在这两例患者中,低剂量的特利加压素(0.01 - 0.0 mg h(-1))足以通过增加体循环血管阻力来恢复血压。血流动力学反应迅速、长效、剂量依赖性,且在停药后数小时内可逆。特利加压素剂量方案的进一步增加显著降低了心脏功能。特利加压素同时引起皮肤血管区域内的血管收缩,导致局部皮肤坏死。内脏血管区域似乎也以同样的方式收缩。需要进一步研究以更好地理解和明确特利加压素在治疗对儿茶酚胺难治的血管扩张性感染性休克中的作用。